Results 51 to 60 of about 510,033 (220)

Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes [PDF]

open access: yes, 2012
BACKGROUND: In Switzerland and other developed countries, the number of tuberculosis (TB) cases has been decreasing for decades, but HIV-infected patients and migrants remain risk groups.
Thomas Bodmer   +63 more
core   +3 more sources

PANGEA-HIV/PANGEA-Sequences: v1.0.0

open access: yes, 2023
<h2><a href="https://github.com/pangea-hiv/#hiv-consensus-sequence-repository-of-the-pangea-hiv-consortium">HIV Consensus Sequence Repository</a><br><a href="https://github.com/pangea-hiv/#hiv-consensus-sequence-repository-of ...
PANGEA-HIV Consortium
core   +1 more source

Human herpesvirus 8 seropositivity among sexually active adults in Uganda.

open access: yesPLoS ONE, 2011
IntroductionSexual transmission of human herpesvirus 8 (HHV8) has been implicated among homosexual men, but the evidence for sexual transmission among heterosexual individuals is controversial. We investigated the role of sexual transmission of HHV8 in a
Fatma M Shebl   +9 more
doaj   +1 more source

HIV Risk Behavior and Beliefs of HIV-Seropositive Drug Users [PDF]

open access: yesJournal of Drug Issues, 1992
To assess HIV risk behavior, beliefs, attitudes and intentions among HIV-seropositive drug users (DUs), we studied 122 HIV-positive DUs (including ninety-five current injectors) participating in a longitudinal HIV-study among DUs in Amsterdam. All were familiar with their serostatus. Over a period of four months, 20% of the sample put others at risk of
Hartgers, C.   +4 more
openaire   +3 more sources

Clinical progress note: Mumps

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Mumps was a common childhood viral illness before the implementation of the measles, mumps, and rubella (MMR) vaccination in 1967. There was a significant decrease in mumps cases in the postvaccine era; however, there has been an increase in outbreaks in the United States over the past two decades.
Sarah Ludvigsen, Mati Segev
wiley   +1 more source

[Thrombocytopenia in HIV-1 seropositive hemophiliacs].

open access: yes[Rinsho ketsueki] The Japanese journal of clinical hematology, 1993
When platelet counts were compared in 1986 and 1992 in 117 anti-HIV antibody positive and negative hemophilia patients, a clear decrease was found in the positive group. In 1992 platelet counts < 150 x 10(9) were present in 23.5% of the positive group in contrast to 5.8% of the negative group. Comparing platelet counts with other clinical parameters, a
FUKUTAKE, Katsuyuki   +7 more
openaire   +2 more sources

Bringing Gene Therapy Into Real World Clinical Practice

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Adeno‐associated virus (AAV)‐based gene therapy for haemophilia has shifted therapeutic paradigms by enabling hepatic gene transfer, restoring endogenous clotting factor expression, and reducing reliance on conventional prophylactic treatments. Two products, valoctocogene roxaparvovec (haemophilia A) and etranacogene dezaparvovec (
Wolfgang Miesbach   +2 more
wiley   +1 more source

A scoping review of the acceptability, feasibility and effectiveness of opt‐out blood‐borne virus (BBV) testing in secondary healthcare settings, in the UK and similar settings, using APEASE criteria

open access: yesHIV Medicine, EarlyView.
Abstract Background Earlier diagnosis of blood‐borne viruses (BBVs)—HIV, hepatitis B (HBV) and hepatitis C (HCV)—remains a significant public‐health focus. Opt‐out testing in secondary healthcare settings can improve early diagnosis and linkage to care as part of BBV transmission elimination targets.
Becky Metcalfe   +6 more
wiley   +1 more source

Measles immunity among pregnant women aged 15–44 years in Namibia, 2008 and 2010

open access: yesInternational Journal of Infectious Diseases, 2016
Background: Namibia experienced a large measles outbreak starting in 2009, with 38% of reported cases in adults, including women of reproductive age. Population immunity was assessed among pregnant women to determine whether immunization activities were ...
Cristina V. Cardemil   +14 more
doaj   +1 more source

BLIMP‐1 and CD39 expression define human effector memory regulatory T cells in blood and recall responses to viruses

open access: yesImmunology &Cell Biology, EarlyView.
This study found that BLIMP‐1 is highly expressed in activated effector/memory human regulatory T cells, especially CD39+ Tregs, where it is associated with increased IL‐10 production and a conserved phenotype across blood and lung tissues during immune responses such as SARS‐CoV‐2 infection.
Chansavath Phetsouphanh   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy